Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now ...
US Commerce Secretary Howard Lutnick‘s hedge fund Cantor Fitzgerald LP increased the firm’s exposure to Bitcoin (CRYPTO: BTC) ...
Senate Commerce Committee chair Ted Cruz said Lutnick will focus on issues including expanding commercial access to wireless ...
Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued to ...
Cantor Fitzgerald raised the firm’s price target on Five9 (FIVN) to $57 from $46 and keeps an Overweight rating on the shares. Give9 reported ...
Fintel reports that on February 19, 2025, Cantor Fitzgerald downgraded their outlook for Supernus Pharmaceuticals ...
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take as in previous years.
Cantor Fitzgerald lowered the firm’s price target on Nice (NICE) to $161 from $176 and keeps a Neutral rating on the shares. Nice reported ...